Latest Update on Urgent Virus Outbreaks: COVID-19, Respiratory Syncytial Virus, and Influenza

Program Description

The IAS–USA Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic. 

This Dialogue will provide a robust and relevant discussion of urgent virus outbreaks, particularly COVID-19, respiratory syncytial virus (RSV), and influenza, at the time. 

• COVID-19: Discuss the latest epidemiology data on the XBB, BQ1, and BQ1.1 variants of COVID-19; updates on new COVID-19 vaccines and bivalent boosters; growing issue of long-COVID; public health interventions and the need to reinstitute prior mandates; and the problem of misinformation, including the concept of “immunity debt”
• RSV: Update on RSV in both pediatrics and adults; information on medication shortages; and current status and data on RSV vaccines awaiting FDA approval
• Influenza: Latest epidemiology data on influenza and compare it to recent years; update on the influenza vaccine; and importance of diagnosing and treating influenza

Note, Dialogues are intended for healthcare clinicians and researchers. 

Sign Up

Please use the following link to sign up https://us06web.zoom.us/webinar/register/WN_q6iy28rRTq–Gr5bqG8g6w or click the button below.

Zoom will send an email that includes a unique link to join the Zoom activity and allow you to add this information to your calendar. Zoom will send 1-day and 1-hour reminders.

Sign Up